No profile data available.
BioStem Technologies, Inc. (BSEM) is a healthcare company in the additional specific healthcare equipment industry, based in Fort Lauderdale, United States, with about 73 full-time employees.
It reported revenue of $301.83 million for fiscal year 2024, up 1708.9% from fiscal year 2023, and net income of $31.88 million. Its market capitalization was $46.12 million as of October 9, 2026.
Figures from company filings and market data; latest fiscal year ended December 31, 2024; market data as of October 9, 2026.
BioStem Technologies, Inc. engages in the development, manufacturing, and commercialization of placental-derived allografts for advanced wound care and regenerative therapies in the United States.
BioStem Technologies reported $301.83 million in revenue for fiscal year 2024, up 1708.9% from $16.69 million in fiscal year 2023.
$46.12 million as of October 9, 2026.
Listed companies of a similar size in the same industry (additional specific healthcare equipment) include SkinHealth Systems Inc. (SKIN), Spectral AI, Inc. (MDAI), Envoy Medical, Inc. (COCH), Milestone Scientific Inc. (MLSS).